NasdaqCM - Delayed Quote USD

Bon Natural Life Limited (BON)

Compare
1.8800 +0.1800 (+10.59%)
At close: November 26 at 4:00 p.m. EST
1.8400 -0.04 (-2.13%)
After hours: November 26 at 6:38 p.m. EST
Loading Chart for BON
DELL
  • Previous Close 1.7000
  • Open 1.6900
  • Bid --
  • Ask --
  • Day's Range 1.6900 - 1.9200
  • 52 Week Range 1.2300 - 6.9900
  • Volume 28,979
  • Avg. Volume 42,236
  • Market Cap (intraday) 7.465M
  • Beta (5Y Monthly) -1.18
  • PE Ratio (TTM) 0.40
  • EPS (TTM) 4.7500
  • Earnings Date Sep 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

www.bnlus.com

96

Full Time Employees

September 30

Fiscal Year Ends

Basic Materials

Sector

Specialty Chemicals

Industry

Recent News: BON

View More

Performance Overview: BON

Trailing total returns as of 2024-11-26, which may include dividends or other distributions. Benchmark is

.

YTD Return

BON
65.19%
S&P 500
26.24%

1-Year Return

BON
56.58%
S&P 500
32.07%

3-Year Return

BON
96.46%
S&P 500
28.08%

5-Year Return

BON
97.02%
S&P 500
41.14%

Compare To: BON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BON

View More

Valuation Measures

As of 2024-11-25
  • Market Cap

    6.71M

  • Enterprise Value

    12.46M

  • Trailing P/E

    0.36

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.09

  • Price/Book (mrq)

    0.18

  • Enterprise Value/Revenue

    0.49

  • Enterprise Value/EBITDA

    2.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.65%

  • Return on Assets (ttm)

    3.88%

  • Return on Equity (ttm)

    6.61%

  • Revenue (ttm)

    25.56M

  • Net Income Avi to Common (ttm)

    2.47M

  • Diluted EPS (ttm)

    4.7500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    717.88k

  • Total Debt/Equity (mrq)

    17.84%

  • Levered Free Cash Flow (ttm)

    -978.17k

People Also Watch